Historical record - last NADAC effective date: 1/1/2017

Product Information

BARACLUDE 1 MG TABLET is a brand product labeled by E.R. Squibb & Sons, L.L.C., priced at $43.9221 per EA under NDC 00003161212. Its NADAC has been published 216 times since Nov 28, 2013.

FDA first approved this application on Mar 29, 2005. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

The High Outlier badge above means this manufacturer's average price in the entecavir market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

BARACLUDE 1 MG TABLET

entecavir
$43.9221per EA
High Outlier

Strength

1 mg/1

NDC

00003161212

Classification

Brand

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

1/1/2017

Active Ingredients

ENTECAVIR

Approval Type

New Drug (NDA)

FDA Application

NDA021797

FDA Approved

3/29/2005

TE Code

AB

On Market Since

3/29/2005

Pharmacological Classes

Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor
Nucleoside Analog
Nucleoside Reverse Transcriptase Inhibitors

Price Statistics

The NADAC for BARACLUDE 1 MG TABLET has been published 216 times since Nov 28, 2013, and over the history we have for it it has risen 29.6%. The table below summarizes its recorded NADAC range and movement.

Current price$43.9221 per EA
All-time high$43.9221 (Jan 10, 2018)
All-time low$33.8956 (Nov 28, 2013)
Median price$40.2408
Average price$40.7433
Largest weekly change+12.0% (Jan 8, 2014)
Weeks tracked216
Tracking sinceNov 28, 2013

Price History

1W

N/A

1M

N/A

3M

N/A

6M

N/A

1Y

N/A

3Y

N/A

5Y

N/A

All

+29.6%

Last surveyed Jan 10, 2018 — this NDC no longer appears in the current weekly NADAC file.

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the entecavir market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Frequently asked questions

What is the NADAC price of BARACLUDE 1 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for BARACLUDE 1 MG TABLET, manufactured by E.R. Squibb & Sons, L.L.C., is $43.9221 per EA (NDC 00003161212), effective Jan 10, 2018.

How has the price of BARACLUDE 1 MG TABLET changed over time?

Over the history we have for it, the NADAC for BARACLUDE 1 MG TABLET has risen 29.6%. It has been tracked across 216 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for BARACLUDE 1 MG TABLET?

Since Nov 28, 2013, the NADAC for BARACLUDE 1 MG TABLET has ranged from a low of $33.8956 (Nov 28, 2013) to a high of $43.9221 (Jan 10, 2018), with a median of $40.2408 per EA.

Are there cheaper alternatives to BARACLUDE 1 MG TABLET?

No other NADAC-published product currently shares the active ingredient and strength of BARACLUDE 1 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures BARACLUDE 1 MG TABLET?

BARACLUDE 1 MG TABLET (NDC 00003161212) is labeled by E.R. Squibb & Sons, L.L.C., and CMS classifies it as a brand product.